HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Fast track program reduced time-to-treatment initiation by 40%
-
- Antibody-drug conjugate shows promise for post-transplant relapsed, refractory HL
- Anticlotting drugs rarely indicated for children with pelvic, femur fractures
- Bevacizumab offered no OS benefit in metastatic breast cancer
- Hospital opens Barrett's esophagus treatment center
- Liver cancer surveillance likely unnecessary in patients with alcoholic cirrhosis
- MD Anderson president to join science academy
- More excisions performed on younger patients, but fewer malignant tumors identified
- Statins reduced risk for cancer, mortality in heart transplant recipients
-
- Transfusion refusal after cardiac surgery failed to reduce survival
- FDA approves genetic test for patients with metastatic colorectal cancer
- FDA issues drug safety communication about heart risks with ondansetron
- FDA releases draft guidance on pCR as potential endpoint for breast cancer drugs
- Improved outcomes sought for post-transplant patients with chronic GVHD
- Adjuvant therapy in older colorectal cancer patients may offer significant survival benefit
- Blood-clot drug appears safe in warfarin-treated patients after stroke
- Circulating tumor cells predict survival, recurrence in early-stage breast cancer
-
- Gatorade/Miralax colonoscopy prep effective, not improved by bisacodyl
- Genetic variants may predict smoking rates, lung cancer risk
- Immunohistochemically identified double-hit lymphoma associated with poor outcomes
- Longer cervical cancer screening intervals feasible for HIV-positive women with negative co-test results
- Melanoma mortality decline, education linked among non-Hispanic whites
- MicroRNA-320a regulated glycolysis, growth rate of lung adenocarcinomas in ventilator-assisted patients
- Myelodysplastic syndromes linked to abnormal stem cells
- Preoperative chemoradiotherapy doubled OS in esophageal, esophagogastric junction cancer
-
- Review: Evidence of effectiveness in HT for chronic conditions in women
- Addition of aflibercept to topotecan improved PFS in SCLC
- Biochemotherapy may be attractive alternative to interferon in high-risk melanoma
- Large European, US studies find no insulin glargine–cancer connection
- LUX-Lung 3: Afatinib extended PFS in EGFR-mutated lung adenocarcinomas
- Phosphorus-32 skin patches effectively treated basal cell carcinoma
- Primary care providers uninformed of long-term chemotherapy side effects
- Standard weekly paclitaxel offered greater benefit than newer, costlier treatments
-